Senior / Key Personnel FCOI’s

The University is required to maintain a website to ensure public accessibility to the Conflict of Interest (COI) policy and information concerning any significant financial interest disclosed to the University that meets the following three criteria:

  • The significant financial interest was disclosed and is still held by the senior/key personnel
  • The University determines that the significant financial interest is related to funded research or to scholarly and/or educational activities funded under external grants, contracts or cooperative agreements; and
  • The University determines that the significant financial interest is a Financial Conflict of Interest (FCOI).

The following personnel have met the above criteria:

Cote, Richard, M.D.

Title/role: Principal Investigator
Name of SFI entity: Filtini, Inc.
Nature of SFI: Equity Ownership; Consultant; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Cote owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Datar, Ram, Ph.D.

Title/role: Co-Investigator
Name of SFI entity: Filtini, Inc.
Nature of SFI: Equity Ownership; Consultant; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Datar owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Gupta, Vineet, Ph.D

Title/role: Principal Investigator
Name of SFI entity: Adhaere Pharmaceuticals
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Gupta owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. Dr. Gupta has also received compensation from this company for travel in the amount of $0-$4,999.

Webster, Keith, Ph.D.

Title/role: Principal Investigator
Name of SFI entity: Integene International
Nature of SFI: Equity Ownership; Inventor of Intellectual Property; Board of Directors
Approximate Dollar Amount: Dr. Webster owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Harbour, James, M.D.

Title/role: Principal Investigator
Name of SFI entity: Washington University; Castle Biosciences
Nature of SFI: Royalties received as Inventor of Intellectual Property; Consultant
Approximate Dollar Amount: Dr. Harbour received royalties in the amount of $20,000-40,000; compensation from this company in the amount of $10,000-20,000.

Levy, Robert, Ph.D.

Title/role: Principal Investigator
Name of SFI entity: Allergan
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Levy received compensation from this company in the amount of $5,000-9,999.

Liddle, Howard, E.D.D.

Title/role: Principal Investigator; Study Team Member
Name of SFI entity: MDFT International
Nature of SFI: Chairman; Board of Directors; Consultant
Approximate Dollar Amount: Dr. Liddle received compensation as salary from this company in the amount of $5,000-9,999. Dr. Liddle's spouse, Dr. Dakof, also has a professional relationship with this company. She received between $20,000-100,000 as the Director of MDFT International.

Hare, Joshua, M.D.

Title/role: Principal Investigator
Name of SFI entity: Vestion
Nature of SFI: Equity Ownership
Approximate Dollar Amount: Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. In addition, Dr. Hare has received compensation in the amount of $20,000 - $100,000.
Title/role: Principal Investigator
Name of SFI entity: Biscayne Pharmaceuticals
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Ricordi, Camillo, M.D.

Title/role: Team Member
Name of SFI entity: Ophysio, Inc
Nature of SFI: Equity Ownership; Inventor of Intellectual Property; Advisory Board
Approximate Dollar Amount: Dr. Ricordi owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Alejandro, Rodolfo, M.D.

Title/role: Principal Investigator
Name of SFI entity: Converge
Nature of SFI: Equity Ownership
Approximate Dollar Amount: Dr. Alejandro owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

lnverardi, Luca, M.D.

Title/role: Team Member
Name of SFI entity: Ophysio, Inc
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Inverardi owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Pileggi, Antonello, M.D., Ph.D.

Title/role: Principal Investigator
Name of SFI entity: Converge Biotech
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Pileggi owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Stabler, Cherie, Ph.D.

Title/role: Principal Investigator
Name of SFI entity: Converge Biotech
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr.Stabler owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Molano, Ruth, D.V.M.

Title/role: Principal Investigator
Name of SFI entity: Converge Biotech
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr.Molano owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Dakof, Gayle, Ph.D.

Title/role: Co-Investigator
Name of SFI entity: MDFT International
Nature of SFI: Director
Approximate Dollar Amount: Dr. Dakof received compensation as salary and travel from this company in the amount of $20,000-100,000. Dr. Dakof's spouse, Dr. Liddle, also has a professional relationship with this company. He received between $5,000-9,999 as the Chairman, Board of Directors, and consultant for MDT International.

Rowe, Cynthia (Cindy), M.D.

Title/role: Principal Investigator; Study Team Member
Name of SFI entity: MDFT International
Nature of SFI: Associate Director; Board of Directors & trainer; Consultant
Approximate Dollar Amount: Dr. Rowe received compensation as salary and travel from this company in the amount of $20,000-100,000.

Kapiloff, Michael, M.D.

Title/role: Principal Investigator
Name of SFI entity: Anchored RSK3 Inhibitors, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Kapiloff owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Title/role: Principal Investigator
Name of SFI entity: Cardiac RSK3 Inhibitors
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Kapiloff owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Gustafson, David, Ph.D.

Title/role: Sub-Contractor
Name of SFI entity: D. Gustafson & Associates
Nature of SFI: Sole Ownership; Consultant
Approximate Dollar Amount: Dr. Gustafson received compensation as salary from this company in the amount of $20,000-100,000. He is also a consultant for this company.

Anthony Capobianco, Ph.D.

Title/role: Principal Investigator; Study Team Member
Name of SFI entity: StemSynergy Therapeutics, Inc.
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Capobianco owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Jeffrey Goldberger, M.D.

Title/role: Team Member
Name of SFI entity: Gold-T Tech, Inc.
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Goldberger owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Wenche Jy, Ph.D.

Title/role: Team Member
Name of SFI entity: RxMP Therapeutics, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Jy owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Yeon Ahn, M.D.

Title/role: Team Member
Name of SFI entity: RxMP Therapeutics, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Ahn owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Dalton Dietrich, Ph.D.

Title/role: Principal Investigator
Name of SFI entity: InflamaCORE, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Dietrich owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Juan Pablo de Rivero Vaccari, Ph.D.

Title/role: Team Member
Name of SFI entity: InflamaCORE, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. de Rivero Vaccari owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Robert Keane, Ph.D.

Title/role: Team Member
Name of SFI entity: InflamaCORE, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Keane owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Robert Knighton, M.D.

Title/role: Team Member
Name of SFI entity: Carl Zeiss Meditec
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Knighton has received compensation from this company in the amount of $10,000-$20,000.

Ashok Saluja, Ph.D.

Title/role: Principal Investigator
Name of SFI entity: Minneamrita Therapeutics
Nature of SFI: Equity; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Saluja owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Sulagna Banerjee, Ph.D.

Title/role: Principal Investigator and Team Member
Name of SFI entity: Minneamrita Therapeutics
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Banerjee has received compensation from this company in the amount of $10,000-$20,000.

Elizabeth Franzmann, M.D.

Title/role: Team Member
Name of SFI entity: Vigilant Biosciences
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Franzmann owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Christopher Fraker, Ph.D.

Title/role: Team Member
Name of SFI entity: Ophysio, Inc
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Fraker owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Juan Dominguez-Bendala, Ph.D.

Title/role: Principal Investigator
Name of SFI entity: Ophysio, Inc
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Dominguez-Bendala owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Alice Tomei, Ph.D.

Title/role: Team Member
Name of SFI entity: Converge, Biotech
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Tomei owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Shanta Dhar, Ph.D.

Title/role: Principal Investigator
Name of SFI entity: Partikula LLC
Nature of SFI: Consultant; Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Dhar has received compensation in the amount of $20,000 - $100,000 from this company. In addition, Dr. Dhar owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Stephan Züchner, M.D.

Title/role: Principal Investigator
Name of SFI entity: ViaGenetics, LLC
Nature of SFI: Equity Ownership; Board of Directors
Approximate Dollar Amount: Dr. Dr. Züchner owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

Rebecca Schüle, M.D.

Title/role: Principal Investigator
Name of SFI entity: ViaGenetics, LLC
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Schüle has received compensation in the amount of $0 - $10,000 from this company.

Philip Harvey, Ph.D.

Title/role: Team Member
Name of SFI entity: i-Function, Inc.
Nature of SFI: Equity Ownership; Chief Scientific Officer
Approximate Dollar Amount: Dr. Harvey owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.


SFI - Significant Financial Interest

The information provided is current as of 03/28/17 and is subject to updates, on at least an annual basis and within 60 days of the Institution’s identification of a new FCOI.